Please login to the form below

Not currently logged in

Excellence in Innovation

Sponsored by

Back to Results


Bayer iMCM Lighthouse Project

by Bayer
with support from Oi Ltd

Summary of work

A key product in Bayer's Established Products portfolio in the UK is Nebido.

Nebido is the market leader in the testosterone market where currently only 8% of potential patients are treated.

In 2015, sales of Nebido declined in the UK following a decision to stop promotion. This decline prompted an initiative to find a novel approach to restore the growth curve in 2016 that did not involve traditional sales methods.

The Bayer Lighthouse Project was developed to help UK healthcare professionals identify and treat patients with hypogonadism, a condition that is under-diagnosed and under-treated by clinicians. By growing the testosterone market and reinforcing Nebido as the gold standard therapy for all hypogonadal patients Bayer could restore Nebido back to growth.

The campaign was built upon the core foundation of a traditional educational programme:

The ‘Restore the Man’ clinical seminars.

An integrated multichannel strategy was developed to support the educational programme which provided an intelligent matrix of content that evolved customer conversations across channels from event registration through to remote-detailing discussions with multichannel account managers. Customers who registered for the programme were provided with dynamic content recommendations based on their individual preferences and behaviour (by utilising a profiling matrix and leveraging customer insights across channels).

The campaign was successful in restoring growth of Nebido, achieving +9% absolute growth in 2016.

Judges' comments

This entry ticks all the boxes. It was clearly conceived as an omni-channel campaign and is put together very well. It does a good job using innovative practice to reactivate a mature brand.


Merck Growth Hormone eHealth Programme - by Merck
with support from W2O Group

Highly commended

Video Journal of Hematological Oncology (VJHemOnc) - by Magdalen Medical Publishing
with support from Brandcast Health


Bayer iMCM Lighthouse Project - by Bayer
with support from Oi Ltd

‘Make The Connection’ – Helping Paediatricians Join the Dots to Recognise MPS I - by Sanofi Genzyme
with support from Health IQ, Republic M! and Havas Life Medicom

Key dates

Entry deadline 26 August 2022
Extended entry deadline 2 September 2022*
*additional fee applies
Judging Day 6 October 2022
Company/Team of the Year Interviews 21 October 2022
PMEA Event 23 November 2022